Biogen | DEBITO

Debt Cambiamento Data
AbbVie USD 60.75B 269M 2023-09
Acadia Pharmaceuticals USD 0 0 2022-06
ALKERMES USD 291.37M 635K 2023-09
Amgen USD 64.61B 4.15B 2023-12
Bayer EUR 47.42B 907M 2023-09
Eli Lilly USD 20.17B 1.35B 2023-09
Gilead Sciences USD 24.98B 264M 2023-09
Incyte USD 32.6M 678K 2023-12
Intra Cellular Therapies USD 0 0 2022-06
Moderna USD 575M 150M 2023-12
Neurocrine Biosciences USD 169.9M 200K 2023-09
Pfizer USD 63.6B 1.74B 2023-09
PTC Therapeutics USD 2.12B 762.21M 2023-12
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
Teva Pharmaceutical Industries USD 19.97B 704M 2023-09
Ultragenyx Pharmaceutical USD 0 0 2022-06
United Therapeutics USD 700M 100M 2023-12
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



Biogen DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.